PapersFlow Research Brief
Viral Infections and Outbreaks Research
Research Guide
What is Viral Infections and Outbreaks Research?
Viral Infections and Outbreaks Research is the study of viral pathogens such as Ebola and SARS-CoV-2, focusing on their transmission dynamics, cell entry mechanisms, spike glycoprotein structures, immune responses, vaccine development, and public health interventions during outbreaks.
This field includes 48,508 works on topics like Ebola virus transmission, pathogenesis, genomic surveillance, vaccine development, reservoirs, and immune responses. Research also addresses SARS-CoV-2 cell entry via ACE2 and TMPRSS2, as shown in highly cited studies. Growth rate over the past five years is not available in the data.
Topic Hierarchy
Research Sub-Topics
Ebola Virus Transmission Dynamics
This sub-topic models contact tracing, R0 estimation, and superspreading events in Ebola outbreaks using epidemiological data. Researchers integrate genomic and mobility data for prediction.
Ebola Vaccine Development and Trials
Focuses on rVSV-ZEBOV and other candidates, covering phase III efficacy, immunogenicity, and ring vaccination designs. Studies assess durability and cross-protection against variants.
Ebola Pathogenesis and Host Response
Investigates viral entry, immune evasion, endothelial damage, and cytokine storms in animal models and humans. Research identifies therapeutic targets like vascular leakage.
Ebola Genomic Surveillance
This area develops real-time sequencing pipelines for outbreak tracking, lineage identification, and evolution monitoring. Studies link mutations to transmissibility and vaccine escape.
Ebola Reservoirs and Zoonotic Spillover
Researchers survey bats, primates, and environmental samples for filovirus reservoirs using serology and PCR. Ecological modeling predicts spillover risks in Central Africa.
Why It Matters
Viral Infections and Outbreaks Research informs containment strategies and medical countermeasures for pandemics. Hoffmann et al. (2020) in "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (21,021 citations) identified that SARS-CoV-2 entry relies on ACE2 and TMPRSS2, blocked by the protease inhibitor camostat, enabling repurposing of existing drugs. Walls et al. (2020) in "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" (8,959 citations) detailed spike structures for vaccine design, contributing to COVID-19 vaccines. Wu et al. (2020) in "Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study" (4,856 citations) modeled spread from Wuhan, guiding travel restrictions. Rerks-Ngarm et al. (2009) in "Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand" (3,009 citations) showed a vaccine regimen reduced HIV infection risk by 31% in a heterosexual population. Wilder-Smith and Freedman (2020) in "Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak" (2,806 citations) highlighted isolation and quarantine's role in controlling SARS-CoV-2, as proven in the 2003 SARS epidemic.
Reading Guide
Where to Start
"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" by Hoffmann et al. (2020), as it provides a foundational, highly cited (21,021 times) explanation of SARS-CoV-2 entry mechanisms accessible via its clear experimental validation.
Key Papers Explained
Hoffmann et al. (2020) "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" establishes ACE2/TMPRSS2 dependence, built upon by Walls et al. (2020) "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" detailing spike cryo-EM structures, and Shang et al. (2020) "Cell entry mechanisms of SARS-CoV-2" refining activators via pseudovirus assays. Wu et al. (2020) "Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study" applies entry insights to spread models, extended by Anderson et al. (2020) "How will country-based mitigation measures influence the course of the COVID-19 epidemic?" on interventions. Matzinger (2002) "The Danger Model: A Renewed Sense of Self" provides immune theory context for responses.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
No recent preprints or news from the last 12 months are available, so frontiers remain tied to established mechanisms like spike antigenicity and modeling from 2020 papers.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Block... | 2020 | Cell | 21.0K | ✓ |
| 2 | Structure, Function, and Antigenicity of the SARS-CoV-2 Spike ... | 2020 | Cell | 9.0K | ✓ |
| 3 | Nowcasting and forecasting the potential domestic and internat... | 2020 | The Lancet | 4.9K | ✓ |
| 4 | The Danger Model: A Renewed Sense of Self | 2002 | Science | 4.1K | ✕ |
| 5 | How will country-based mitigation measures influence the cours... | 2020 | The Lancet | 3.9K | ✓ |
| 6 | Cell entry mechanisms of SARS-CoV-2 | 2020 | Proceedings of the Nat... | 3.4K | ✓ |
| 7 | Characterization of spike glycoprotein of SARS-CoV-2 on virus ... | 2020 | Nature Communications | 3.4K | ✓ |
| 8 | Infectious Diseases Society of America | 1969 | The Journal of Infecti... | 3.3K | ✕ |
| 9 | Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection ... | 2009 | New England Journal of... | 3.0K | ✓ |
| 10 | Isolation, quarantine, social distancing and community contain... | 2020 | Journal of Travel Medi... | 2.8K | ✓ |
Frequently Asked Questions
What mechanisms enable SARS-CoV-2 cell entry?
SARS-CoV-2 uses ACE2 as its entry receptor and TMPRSS2 as an entry activator. Hoffmann et al. (2020) showed this process is blocked by the clinically proven protease inhibitor camostat. Shang et al. (2020) in "Cell entry mechanisms of SARS-CoV-2" confirmed these mechanisms using biochemical and pseudovirus assays compared to SARS-CoV.
How does the structure of the SARS-CoV-2 spike glycoprotein contribute to infection?
The SARS-CoV-2 spike glycoprotein mediates receptor binding and membrane fusion for cell entry. Walls et al. (2020) determined its structure, function, and antigenicity using cryo-EM. Ou et al. (2020) in "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV" characterized its role and cross-reactivity.
What public health measures control viral outbreaks?
Isolation separates ill persons from non-infected ones, while quarantine restricts contacts with surveillance. Wilder-Smith and Freedman (2020) emphasized these measures' success in the 2003 SARS epidemic for 2019-nCoV. Anderson et al. (2020) in "How will country-based mitigation measures influence the course of the COVID-19 epidemic?" modeled their impact on epidemic trajectories.
What is the Danger Model in immune response?
The Danger Model posits the immune system responds to danger signals rather than self-nonself distinction. Matzinger (2002) in "The Danger Model: A Renewed Sense of Self" critiqued the self-nonself paradigm after 50 years of evidence. It applies to responses in viral infections like Ebola.
How effective was the ALVAC-AIDSVAX vaccine for HIV?
The ALVAC-HIV and AIDSVAX B/E regimen reduced HIV-1 infection risk in a Thai community with heterosexual risk. Rerks-Ngarm et al. (2009) reported this modest benefit without affecting viral load or CD4 counts in infected subjects. It provides insights for viral vaccine development.
Open Research Questions
- ? How do variations in SARS-CoV-2 spike glycoprotein affect cross-reactivity with SARS-CoV immune responses?
- ? What are the precise zoonotic reservoirs and transmission pathways for Ebola virus?
- ? How can genomic surveillance improve real-time forecasting of viral outbreak spread?
- ? Which public health measures most effectively balance epidemic control with socioeconomic impacts?
- ? What danger signals drive adaptive immune responses during acute viral infections?
Recent Trends
No recent preprints from the last 6 months or news from the last 12 months are available.
The field has 48,508 works with no specified 5-year growth rate.
Citation leaders from 2020, such as Hoffmann et al. (21,021 citations), indicate sustained focus on SARS-CoV-2 entry post-initial outbreak.
Research Viral Infections and Outbreaks Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Viral Infections and Outbreaks Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers